Mission Bio, the leader in single-cell multiomics, published research in Molecular Therapy Advances showing that their ...

When it comes to matching the commercial scale-up to the innovations taking place across Kite’s pipeline, Alquist admitted ...

There has been a swing towards in vivo CAR-T therapies lately, as big pharmas sign acquisition deals and new therapies hit ...

Comedian Jeff Dunham discusses his Discovery docuseries, "The Cars That Drove Us," the show's inspiration, his car history, ...

Learn how to generate vector CAD-style drawings from Google Earth imagery using Nano Banana Pro for faster architectural ...

Eli Lilly is picking up its second in vivo CAR-T company of the year, paying $3.25 billion in upfront cash for Kelonia ...

Novartis is “continuing to evaluate” the in vivo CAR-T space, although the pharma’s CEO has told Fierce Biotech that no deals ...

The global lentiviral vector CDMO market is projected to grow at a CAGR of 8% over the next five years. This growth is driven by rising demand for gene and cell therapies, an expanding pipeline of ...

Researchers developed a gorilla adenovirus platform with inherent tumor selectivity, lung tropism, and large-gene capacity. The platform could support future development of oncology and respiratory ...

Cha Biotech partners with Miltenyi Biotec to advance CAR-NK therapy in Korea German suppliers lentiviral vectors to power Cha ...

Production cars with space-age styling and vibes strong enough to deserve a rocket launch. The 1959 Cadillac Eldorado as a finned rocket on wheels, Lancia Stratos as a Mars-ready rally wedge, and the ...

Delivery of TPST-2003 lentiviral vector to Cincinnati Children’s Applied Gene and Cell Therapy Center enables manufacturing activities required ...